| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | procollagen galactosyltransferase activity | 6.63e-05 | 4 | 67 | 2 | GO:0050211 | |
| Domain | Glyco_trans_25 | 3.79e-05 | 3 | 67 | 2 | IPR002654 | |
| Domain | Glyco_transf_25 | 3.79e-05 | 3 | 67 | 2 | PF01755 | |
| Domain | VPS10 | 1.26e-04 | 5 | 67 | 2 | SM00602 | |
| Domain | Sortilin_C | 1.26e-04 | 5 | 67 | 2 | PF15901 | |
| Domain | Sortilin-Vps10 | 1.26e-04 | 5 | 67 | 2 | PF15902 | |
| Domain | VPS10 | 1.26e-04 | 5 | 67 | 2 | IPR006581 | |
| Domain | Sortilin_N | 1.26e-04 | 5 | 67 | 2 | IPR031778 | |
| Domain | Sortilin_C | 1.26e-04 | 5 | 67 | 2 | IPR031777 | |
| Domain | PKD | 2.63e-04 | 7 | 67 | 2 | PF00801 | |
| Domain | PKD/Chitinase_dom | 4.49e-04 | 9 | 67 | 2 | IPR022409 | |
| Domain | PKD | 4.49e-04 | 9 | 67 | 2 | SM00089 | |
| Domain | Sialidases | 4.49e-04 | 9 | 67 | 2 | IPR011040 | |
| Domain | PKD | 6.83e-04 | 11 | 67 | 2 | PS50093 | |
| Domain | PKD_dom | 6.83e-04 | 11 | 67 | 2 | IPR000601 | |
| Domain | - | 6.83e-04 | 11 | 67 | 2 | 2.60.40.670 | |
| Domain | FA58C | 2.55e-03 | 21 | 67 | 2 | SM00231 | |
| Domain | FA58C_3 | 2.55e-03 | 21 | 67 | 2 | PS50022 | |
| Domain | FA58C_1 | 2.55e-03 | 21 | 67 | 2 | PS01285 | |
| Domain | FA58C_2 | 2.55e-03 | 21 | 67 | 2 | PS01286 | |
| Domain | F5_F8_type_C | 3.33e-03 | 24 | 67 | 2 | PF00754 | |
| Domain | FA58C | 3.33e-03 | 24 | 67 | 2 | IPR000421 | |
| Domain | IG | 3.96e-03 | 421 | 67 | 6 | SM00409 | |
| Domain | Ig_sub | 3.96e-03 | 421 | 67 | 6 | IPR003599 | |
| Domain | - | 4.20e-03 | 27 | 67 | 2 | 2.130.10.80 | |
| Domain | Ig_I-set | 4.83e-03 | 190 | 67 | 4 | IPR013098 | |
| Domain | ig | 4.83e-03 | 190 | 67 | 4 | PF00047 | |
| Domain | Immunoglobulin | 4.83e-03 | 190 | 67 | 4 | IPR013151 | |
| Domain | I-set | 4.83e-03 | 190 | 67 | 4 | PF07679 | |
| Domain | SH2 | 5.72e-03 | 101 | 67 | 3 | PF00017 | |
| Domain | Gal_Oxidase_b-propeller | 6.60e-03 | 34 | 67 | 2 | IPR015916 | |
| Domain | SH2 | 7.24e-03 | 110 | 67 | 3 | SM00252 | |
| Domain | SH2 | 7.43e-03 | 111 | 67 | 3 | PS50001 | |
| Domain | SH2 | 7.61e-03 | 112 | 67 | 3 | IPR000980 | |
| Domain | - | 7.61e-03 | 112 | 67 | 3 | 3.30.505.10 | |
| Domain | IG_LIKE | 8.26e-03 | 491 | 67 | 6 | PS50835 | |
| Domain | Ig-like_dom | 9.24e-03 | 503 | 67 | 6 | IPR007110 | |
| Domain | - | 9.47e-03 | 663 | 67 | 7 | 2.60.40.10 | |
| Domain | IGc2 | 1.01e-02 | 235 | 67 | 4 | SM00408 | |
| Domain | Ig_sub2 | 1.01e-02 | 235 | 67 | 4 | IPR003598 | |
| Domain | BTB-kelch_protein | 1.04e-02 | 43 | 67 | 2 | IPR017096 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 30822656 | ||
| Pubmed | Core glycosylation of collagen is initiated by two beta(1-O)galactosyltransferases. | 3.77e-06 | 2 | 68 | 2 | 19075007 | |
| Pubmed | 5.73e-06 | 497 | 68 | 8 | 23414517 | ||
| Pubmed | The three sorCS genes are differentially expressed and regulated by synaptic activity. | 1.13e-05 | 3 | 68 | 2 | 15009648 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 28827148 | ||
| Pubmed | Spatiotemporal expression analysis of the growth factor receptor SorCS3. | 1.13e-05 | 3 | 68 | 2 | 24715575 | |
| Pubmed | The genes for the human VPS10 domain-containing receptors are large and contain many small exons. | 2.25e-05 | 4 | 68 | 2 | 11499680 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 12181353 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 9341758 | ||
| Pubmed | Genetic mapping of eight SH3 domain genes on seven mouse chromosomes. | 2.26e-05 | 28 | 68 | 3 | 10087302 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 18647389 | ||
| Pubmed | 6.14e-05 | 347 | 68 | 6 | 17114649 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 2341393 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 9315092 | ||
| Pubmed | 1.68e-04 | 10 | 68 | 2 | 15784911 | ||
| Pubmed | Strain background effects and genetic modifiers of hearing in mice. | 2.05e-04 | 11 | 68 | 2 | 16579977 | |
| Pubmed | Rab27a regulates the peripheral distribution of melanosomes in melanocytes. | 2.05e-04 | 11 | 68 | 2 | 11266470 | |
| Pubmed | Roles of BLOC-1 and adaptor protein-3 complexes in cargo sorting to synaptic vesicles. | 2.45e-04 | 12 | 68 | 2 | 19144828 | |
| Pubmed | Collagen XIV is important for growth and structural integrity of the myocardium. | 2.45e-04 | 12 | 68 | 2 | 22906538 | |
| Pubmed | The Rab7 effector PLEKHM1 binds Arl8b to promote cargo traffic to lysosomes. | 2.90e-04 | 13 | 68 | 2 | 28325809 | |
| Pubmed | 2.90e-04 | 13 | 68 | 2 | 23319608 | ||
| Pubmed | Head bobber: an insertional mutation causes inner ear defects, hyperactive circling, and deafness. | 3.89e-04 | 15 | 68 | 2 | 22383091 | |
| Pubmed | 3.89e-04 | 15 | 68 | 2 | 12183685 | ||
| Pubmed | 4.03e-04 | 73 | 68 | 3 | 24728074 | ||
| Pubmed | 4.44e-04 | 16 | 68 | 2 | 12787792 | ||
| Pubmed | 4.71e-04 | 77 | 68 | 3 | 22973453 | ||
| Pubmed | 5.65e-04 | 18 | 68 | 2 | 22566683 | ||
| Pubmed | Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract. | 5.65e-04 | 18 | 68 | 2 | 27695001 | |
| Pubmed | 6.73e-04 | 202 | 68 | 4 | 29540532 | ||
| Pubmed | 7.44e-04 | 90 | 68 | 3 | 15033168 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 8.68e-04 | 377 | 68 | 5 | 38117590 | |
| Pubmed | 9.28e-04 | 23 | 68 | 2 | 29742433 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.03e-03 | 588 | 68 | 6 | 38580884 | |
| Pubmed | DNA segments mapped by reciprocal use of microsatellite primers between mouse and rat. | 1.10e-03 | 25 | 68 | 2 | 8268655 | |
| Pubmed | Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins. | 1.10e-03 | 25 | 68 | 2 | 2283726 | |
| Pubmed | 1.10e-03 | 25 | 68 | 2 | 24947832 | ||
| Pubmed | 1.19e-03 | 26 | 68 | 2 | 8218172 | ||
| Pubmed | 1.27e-03 | 613 | 68 | 6 | 22268729 | ||
| Pubmed | 1.28e-03 | 27 | 68 | 2 | 26544073 | ||
| Pubmed | Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | 1.33e-03 | 110 | 68 | 3 | 37219487 | |
| Pubmed | 1.48e-03 | 29 | 68 | 2 | 8617512 | ||
| Pubmed | 1.67e-03 | 437 | 68 | 5 | 20562859 | ||
| Pubmed | 1.69e-03 | 31 | 68 | 2 | 27321927 | ||
| Pubmed | The endolysosomal adaptor PLEKHM1 is a direct target for both mTOR and MAPK pathways. | 1.91e-03 | 33 | 68 | 2 | 33452816 | |
| Pubmed | The antiobesity factor WDTC1 suppresses adipogenesis via the CRL4WDTC1 E3 ligase. | 1.95e-03 | 453 | 68 | 5 | 27113764 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.18e-03 | 797 | 68 | 6 | chr19p13 | |
| Cytoband | 18q11.2 | 2.24e-03 | 47 | 68 | 2 | 18q11.2 | |
| Cytoband | 1q42.13 | 2.43e-03 | 49 | 68 | 2 | 1q42.13 | |
| GeneFamily | Collagen beta(1-O)galactosyltransferases | 6.90e-06 | 2 | 48 | 2 | 439 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.69e-04 | 161 | 48 | 4 | 593 | |
| GeneFamily | SH2 domain containing | 2.44e-03 | 101 | 48 | 3 | 741 | |
| Coexpression | PGF_UP.V1_DN | 1.01e-05 | 190 | 68 | 6 | M2673 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NKCELL_DN | 1.28e-05 | 198 | 68 | 6 | M4415 | |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | SHD JARID2 TYRP1 SDK2 ZNF689 OBSCN SORCS2 CHD7 COLGALT2 SLC4A3 GOLGA6L4 PLXNA2 LRRC23 SORCS1 | 2.76e-05 | 1245 | 67 | 14 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 4.76e-07 | 191 | 68 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-06 | 151 | 68 | 5 | f13a117ae26ae525da4f3e837d8f204d00dc6ee3 | |
| ToppCell | ILEUM-non-inflamed-(3)_pDC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.09e-06 | 163 | 68 | 5 | bc5411702badab39143905aa51676b4bbfad2041 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.89e-06 | 168 | 68 | 5 | d03e91f0e0518b33555c0ec98124fc5ed0f11be5 | |
| ToppCell | myeloid-Monocyte-CD14+_Monocyte|Monocyte / Lineage, cell class and subclass | 6.07e-06 | 169 | 68 | 5 | 7c3144a6599787f28662f5b22b8e45f4a115aeda | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 6.24e-06 | 170 | 68 | 5 | 59cb1262ff319349d42b11afbec2a9035b7b79f2 | |
| ToppCell | moderate-Myeloid-pDC|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.24e-06 | 180 | 68 | 5 | a0751ad5e42a21cb107d900abfa9ee967a0069fc | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-pDC|Lung / Manually curated celltypes from each tissue | 8.46e-06 | 181 | 68 | 5 | 3d7f089fb434fbc989f1fa159e22133ae00b2487 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.17e-06 | 184 | 68 | 5 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.02e-05 | 188 | 68 | 5 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.04e-05 | 189 | 68 | 5 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-05 | 190 | 68 | 5 | 1687e133a88c3d036a33a4f8aeefe320a4f02c39 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-05 | 190 | 68 | 5 | 3cfc2646ba25b4bd8bb443cc1f46e18a270a1969 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-pDC|bone_marrow / Manually curated celltypes from each tissue | 1.07e-05 | 190 | 68 | 5 | dde0e34f6a06cdbbb65c86472360c09f0279a572 | |
| ToppCell | BLOOD--(3)_MNP-(3)_DC_(cDC+pDC)|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.07e-05 | 190 | 68 | 5 | 9b8de47f7a2e6137d934ccce32417ab15eb54f46 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 1.07e-05 | 190 | 68 | 5 | 6892c603037b61ef88d6ca01b7592dc0d347d63b | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-05 | 190 | 68 | 5 | d06800ec9f6065c1cc536ed99e8569732272a94f | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.07e-05 | 190 | 68 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-05 | 190 | 68 | 5 | 485073e831afebdb393c7f4b622504d43d1b778b | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.10e-05 | 191 | 68 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-05 | 192 | 68 | 5 | d8f5df2c2a50e567f24ebecc8033ac97ba89d9c5 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.13e-05 | 192 | 68 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-05 | 193 | 68 | 5 | 9661ea0ee7273928c7de2a9f49e853595fa77699 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 1.15e-05 | 193 | 68 | 5 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC-DC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.15e-05 | 193 | 68 | 5 | bdbbfcbe339f23a88dfcc59d53c034bac1605b07 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.15e-05 | 193 | 68 | 5 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.15e-05 | 193 | 68 | 5 | acafe177cd05b2966f5fa26ea02f420f13f2cee5 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-05 | 193 | 68 | 5 | 222829c30ebe47f0ed1e035897e3cd4be10b2a11 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.18e-05 | 194 | 68 | 5 | 69cf7c989ac355c459db13f9d4267b55adc3c174 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.18e-05 | 194 | 68 | 5 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.21e-05 | 195 | 68 | 5 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 1.21e-05 | 195 | 68 | 5 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.24e-05 | 196 | 68 | 5 | fe2dd3a93fe22da93e24a400e154a68757985fc8 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 196 | 68 | 5 | b10b386aacc672949560df2dbb0d4f76cf62e213 | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.27e-05 | 197 | 68 | 5 | 3a5908deb5c5a2bf06019a102fb1652233cf2a2a | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-05 | 198 | 68 | 5 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Biopsy_IPF-Immune-pDCs|Biopsy_IPF / Sample group, Lineage and Cell type | 1.31e-05 | 198 | 68 | 5 | aa8943e6796f619406056cf763b751fe9a9a3e0c | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-05 | 198 | 68 | 5 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.31e-05 | 198 | 68 | 5 | bb03744d8372405c278a0781e2f513bed00cf2b3 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-05 | 198 | 68 | 5 | c8272ac4d90f2367f538f66db40de911ad73ea7f | |
| ToppCell | distal-2-Hematologic-Plasmacytoid_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.34e-05 | 199 | 68 | 5 | 78796b05d28b35e7361b6271d4a3858faa39c45c | |
| ToppCell | mLN-(5)_Dendritic_cell-(54)_pDC|mLN / shred on region, Cell_type, and subtype | 1.34e-05 | 199 | 68 | 5 | 1e738219784a446ee8b0ddeb408e0050e1929e60 | |
| ToppCell | mLN-Dendritic_cell-pDC|mLN / Region, Cell class and subclass | 1.34e-05 | 199 | 68 | 5 | 54f1abb57af7bf8a8b82a38b933f257df3b5d8df | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-05 | 200 | 68 | 5 | ef42753c9fbe3770e3f415cd7ab412654d359edb | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 200 | 68 | 5 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | (54)_pDC|World / shred on Cell_type and subtype | 1.47e-05 | 203 | 68 | 5 | b8ba3e51770ff7b45cd02472f3e63aa4d5816f6f | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.16e-05 | 126 | 68 | 4 | 9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.37e-05 | 146 | 68 | 4 | bee5074c29b132180d35f57d307e342efa9b8cd1 | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.53e-05 | 156 | 68 | 4 | d9d87368e43b24952e70f31f38425e15b716ff5b | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.00e-04 | 158 | 68 | 4 | 2af7beb48272e5368d9ba6b80f08d47ab8556c08 | |
| ToppCell | severe_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 1.03e-04 | 159 | 68 | 4 | e1c48c4ceda116826819ff9adeed7bad6a58844d | |
| ToppCell | severe_COVID-19-pDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.03e-04 | 159 | 68 | 4 | ea5088d27e42b8850455764d53b757ea8d8f14bc | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 162 | 68 | 4 | b502d6af6868425b5c919740e011330c0d3cf3b8 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-pDC|Liver / Manually curated celltypes from each tissue | 1.21e-04 | 166 | 68 | 4 | 24dfa9f3e0842f9ab8350bf6a52ae0d10f2a0c44 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_pDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.24e-04 | 167 | 68 | 4 | 8ddf9da71a7c4ed53588435db826563a24cee616 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 1.24e-04 | 167 | 68 | 4 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-pDC|Lung / Manually curated celltypes from each tissue | 1.27e-04 | 168 | 68 | 4 | 90f713dae3fcbd6ca801a019e3861c263ff3366b | |
| ToppCell | (3)_DC_plasmacytoid|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.27e-04 | 168 | 68 | 4 | 8a913db9b2a1a4ff96fb139734a3834e6aa263f1 | |
| ToppCell | B_cells-pDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.27e-04 | 168 | 68 | 4 | dc8f94424f60ab56facdcffa969e7f3466ee1b6e | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-pDC|lymph-node_spleen / Manually curated celltypes from each tissue | 1.27e-04 | 168 | 68 | 4 | cfed36fece51871a5abbcde71f6bd5e7212357ff | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.33e-04 | 170 | 68 | 4 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-04 | 170 | 68 | 4 | b49f7c8a27078de2137ed04f74cfee30729cfa5e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-04 | 170 | 68 | 4 | 92e765ae0d3adb38d3b22fddb873fd5ccad3fd44 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-04 | 170 | 68 | 4 | 9f8b215caa1afa3cd7104c06fca7cfd790640f66 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-04 | 171 | 68 | 4 | 4fd2c7977c512c51507f055fc74b111c0228ed8b | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.36e-04 | 171 | 68 | 4 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.36e-04 | 171 | 68 | 4 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 171 | 68 | 4 | 39c8ae139e449217091e1481eb5e2aafb8f69a1c | |
| ToppCell | ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, Lineage and Cell Type | 1.36e-04 | 171 | 68 | 4 | 72c448a0dc4c569bd6b465f9aa395f38034e7ea6 | |
| ToppCell | CTRL-Lymphoid-pDC|Lymphoid / Disease state, Lineage and Cell class | 1.45e-04 | 174 | 68 | 4 | ff4315e9fad198cc323fc987deb8652da137cf98 | |
| ToppCell | IIF-Myeloid-pDC|IIF / Disease, Lineage and Cell Type | 1.48e-04 | 175 | 68 | 4 | 35cfb7d0b88678ff5b83ad6e19dbc15a908a3fcc | |
| ToppCell | mild_COVID-19-pDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.48e-04 | 175 | 68 | 4 | b87f279a7519710146c49d6acccb0adedc195965 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.48e-04 | 175 | 68 | 4 | 97fe431f224b592b3076632d101e19136c138dcc | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.48e-04 | 175 | 68 | 4 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | B_cells-pDCs|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.52e-04 | 176 | 68 | 4 | ce757de9e09a225f3f96433f103f43619b0e0dda | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.52e-04 | 176 | 68 | 4 | d6e660df92a3d7dd5732171ee623763faf108476 | |
| ToppCell | CF-Lymphoid-pDC|CF / Disease state, Lineage and Cell class | 1.52e-04 | 176 | 68 | 4 | dd1e529a9e413bcaab43584afbe059e1464ffb53 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 177 | 68 | 4 | 692cd03bf0958ebeec34d41bfe87713a768e9a8e | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.55e-04 | 177 | 68 | 4 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 177 | 68 | 4 | c08583ea68bbeb6b5de852a46b0c0f04792dae55 | |
| ToppCell | COPD-Myeloid-pDC|COPD / Disease state, Lineage and Cell class | 1.55e-04 | 177 | 68 | 4 | 415aa023195a7f961c09529f65cdcc7bb90eaf5d | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 1.58e-04 | 178 | 68 | 4 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC-DC-tDC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.65e-04 | 180 | 68 | 4 | 3d9f3e6f13e558279b4ef43e2c44c7c50d761745 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 180 | 68 | 4 | a37cc885fe3f6cb9df69d43358064c83c18412e7 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 180 | 68 | 4 | 63a6d532b16b8b15c7c9102148d7297ee3afd641 | |
| ToppCell | NS-moderate-d_16-33-Myeloid-pDC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.65e-04 | 180 | 68 | 4 | 144818e69613296cde43f29cb8c20899c670b319 | |
| ToppCell | mild-Myeloid-pDC|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.65e-04 | 180 | 68 | 4 | 38614155fa537d0defda914c531c697be0ef06d8 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-04 | 181 | 68 | 4 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-04 | 181 | 68 | 4 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|Mesenchymal_cells / Lineage and Cell class | 1.69e-04 | 181 | 68 | 4 | f8d914fdc06aaa75a4dc9158daf574ca28fa5432 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.69e-04 | 181 | 68 | 4 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 181 | 68 | 4 | 2e15c46e8260bb04d8264478c19a707221996026 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 1.69e-04 | 181 | 68 | 4 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|tumor_Lung / Location, Cell class and cell subclass | 1.69e-04 | 181 | 68 | 4 | c864ffeb9234b8c29754afc91c85a972889617f4 | |
| ToppCell | facs-Lung-Endomucin-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 182 | 68 | 4 | be9c312a44868d4ee266a64d066feb8c5bce5687 | |
| ToppCell | facs-Lung-Endomucin-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 182 | 68 | 4 | 74dbb706bcaa0f8c922bf3b0424bce5bb27167fa | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-pDC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.72e-04 | 182 | 68 | 4 | 02c0824373a0ecebc922d4ca848ace9d570722c4 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.72e-04 | 182 | 68 | 4 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.72e-04 | 182 | 68 | 4 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | normal_Lung-B_lymphocytes-GrB-secreting_B_cells|normal_Lung / Location, Cell class and cell subclass | 1.76e-04 | 183 | 68 | 4 | c930b957d16f9b0904b6c424acd914532e5cc137 | |
| Drug | TTNPB; Up 200; 0.1uM; MCF7; HG-U133A | 1.30e-06 | 190 | 66 | 7 | 223_UP | |
| Drug | Thalidomide [50-35-1]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 1.49e-06 | 194 | 66 | 7 | 2258_UP | |
| Drug | pioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A | 1.49e-06 | 194 | 66 | 7 | 7523_UP | |
| Drug | Tolazamide [1156-19-0]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.71e-06 | 198 | 66 | 7 | 2842_DN | |
| Drug | Alverine citrate salt [5560-59-8]; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.04e-05 | 193 | 66 | 6 | 6345_DN | |
| Drug | Trolox [53188-07-1]; Down 200; 16uM; MCF7; HT_HG-U133A | 2.23e-05 | 196 | 66 | 6 | 6007_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A | 2.29e-05 | 197 | 66 | 6 | 6611_DN | |
| Drug | Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; HL60; HT_HG-U133A | 2.36e-05 | 198 | 66 | 6 | 2929_UP | |
| Drug | Fipexide hydrochloride [34161-23-4]; Down 200; 9.4uM; PC3; HT_HG-U133A | 2.36e-05 | 198 | 66 | 6 | 5737_DN | |
| Drug | Pentoxifylline [6493-05-6]; Down 200; 14.4uM; PC3; HT_HG-U133A | 2.36e-05 | 198 | 66 | 6 | 7319_DN | |
| Drug | prednisolone; Up 200; 1uM; MCF7; HG-U133A | 2.43e-05 | 199 | 66 | 6 | 265_UP | |
| Drug | 5186324; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 2.43e-05 | 199 | 66 | 6 | 900_DN | |
| Drug | Cefazolin sodium salt [27164-46-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.43e-05 | 199 | 66 | 6 | 4708_DN | |
| Drug | retinoic acid; Down 200; 1uM; PC3; HG-U133A | 2.50e-05 | 200 | 66 | 6 | 447_DN | |
| Drug | hernandezine | 1.23e-04 | 6 | 66 | 2 | CID000072343 | |
| Drug | Ethylnitrosourea | 1.98e-04 | 291 | 66 | 6 | ctd:D005038 | |
| Drug | Betulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 2.16e-04 | 188 | 66 | 5 | 3281_UP | |
| Drug | Ebselen [60940-34-3]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 2.27e-04 | 190 | 66 | 5 | 3458_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A | 2.27e-04 | 190 | 66 | 5 | 1150_DN | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 2.44e-04 | 193 | 66 | 5 | 5268_UP | |
| Drug | Indomethacin [53-86-1]; Up 200; 11.2uM; HL60; HT_HG-U133A | 2.50e-04 | 194 | 66 | 5 | 2377_UP | |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; PC3; HT_HG-U133A | 2.50e-04 | 194 | 66 | 5 | 2118_DN | |
| Drug | Gliquidone [33342-05-1]; Up 200; 7.6uM; HL60; HT_HG-U133A | 2.50e-04 | 194 | 66 | 5 | 3126_UP | |
| Drug | Deoxycorticosterone [64-85-7]; Up 200; 12.2uM; HL60; HT_HG-U133A | 2.56e-04 | 195 | 66 | 5 | 3099_UP | |
| Drug | Amprolium hydrochloride [137-88-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 1479_UP | |
| Drug | Kawain [500-64-1]; Up 200; 17.4uM; PC3; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 7369_UP | |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 7025_UP | |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 2793_UP | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; MCF7; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 3400_UP | |
| Drug | Famotidine [76824-35-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 5011_UP | |
| Drug | Dibucaine [85-79-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 1469_UP | |
| Drug | rottlerin; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 2.62e-04 | 196 | 66 | 5 | 825_UP | |
| Drug | Anabasine [494-52-0]; Up 200; 24.6uM; MCF7; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 6774_UP | |
| Drug | Napelline [5008-52-6]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 6084_UP | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 1658_UP | |
| Drug | Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; PC3; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 5741_DN | |
| Drug | haloperidol; Down 200; 10uM; HL60; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 6203_DN | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 5533_UP | |
| Drug | 6-Hydroxytropinone [5932-53-6]; Down 200; 25.8uM; MCF7; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 4833_DN | |
| Drug | Lovastatin [75330-75-5]; Down 200; 9.8uM; PC3; HT_HG-U133A | 2.69e-04 | 197 | 66 | 5 | 6633_DN | |
| Drug | Furosemide [54-31-9]; Down 200; 12uM; PC3; HT_HG-U133A | 2.69e-04 | 197 | 66 | 5 | 4503_DN | |
| Drug | Cotinine (-) [486-56-6]; Up 200; 22.6uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 66 | 5 | 5246_UP | |
| Drug | felodipine; Up 200; 10uM; MCF7; HG-U133A | 2.69e-04 | 197 | 66 | 5 | 337_UP | |
| Drug | Salbutamol [18559-94-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 66 | 5 | 2306_DN | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; PC3; HT_HG-U133A | 2.69e-04 | 197 | 66 | 5 | 4477_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 66 | 5 | 4730_DN | |
| Drug | STOCK1N-35874; Down 200; 14uM; PC3; HT_HG-U133A | 2.69e-04 | 197 | 66 | 5 | 6583_DN | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.75e-04 | 198 | 66 | 5 | 4546_DN | |
| Drug | Cefamandole sodium salt [30034-03-8]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 2.75e-04 | 198 | 66 | 5 | 3436_UP | |
| Drug | Hecogenin [467-55-0]; Up 200; 9.2uM; PC3; HT_HG-U133A | 2.75e-04 | 198 | 66 | 5 | 5818_UP | |
| Drug | Articaine hydrochloride [23964-57-0]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.75e-04 | 198 | 66 | 5 | 7272_DN | |
| Drug | 16-phenyl tetranor Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 2.75e-04 | 198 | 66 | 5 | 7509_UP | |
| Drug | Bacitracin [1405-87-4]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.75e-04 | 198 | 66 | 5 | 6488_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 2.75e-04 | 198 | 66 | 5 | 3622_UP | |
| Drug | H-89, Dihydrochloride; Down 200; 0.5uM; MCF7; HT_HG-U133A | 2.75e-04 | 198 | 66 | 5 | 6878_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.75e-04 | 198 | 66 | 5 | 6778_UP | |
| Drug | indomethacin, USP; Down 200; 100uM; PC3; HG-U133A | 2.75e-04 | 198 | 66 | 5 | 452_DN | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.81e-04 | 199 | 66 | 5 | 6783_UP | |
| Drug | Cinnarizine [298-57-7]; Up 200; 10.8uM; PC3; HT_HG-U133A | 2.81e-04 | 199 | 66 | 5 | 5817_UP | |
| Drug | Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A | 2.81e-04 | 199 | 66 | 5 | 1797_UP | |
| Drug | Riboflavine [83-88-5]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 2.81e-04 | 199 | 66 | 5 | 2760_DN | |
| Drug | Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 2.81e-04 | 199 | 66 | 5 | 6775_UP | |
| Drug | Etodolac [41340-25-4]; Down 200; 14uM; PC3; HT_HG-U133A | 2.81e-04 | 199 | 66 | 5 | 7246_DN | |
| Drug | Cefalonium [5575-21-3]; Up 200; 8.8uM; HL60; HT_HG-U133A | 2.81e-04 | 199 | 66 | 5 | 2921_UP | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.81e-04 | 199 | 66 | 5 | 4990_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; HL60; HT_HG-U133A | 2.81e-04 | 199 | 66 | 5 | 2449_DN | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.88e-04 | 200 | 66 | 5 | 5299_DN | |
| Drug | Benzocaine [94-09-7]; Up 200; 24.2uM; HL60; HT_HG-U133A | 2.88e-04 | 200 | 66 | 5 | 2167_UP | |
| Drug | Ganciclovir [82410-32-0]; Up 200; 15.6uM; HL60; HT_HG-U133A | 2.88e-04 | 200 | 66 | 5 | 3030_UP | |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Down 200; 10uM; PC3; HT_HG-U133A | 2.88e-04 | 200 | 66 | 5 | 3682_DN | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.88e-04 | 200 | 66 | 5 | 4701_DN | |
| Drug | W-13, hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 2.88e-04 | 200 | 66 | 5 | 643_DN | |
| Drug | Ambroxol hydrochloride [23828-92-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.88e-04 | 200 | 66 | 5 | 3238_DN | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.88e-04 | 200 | 66 | 5 | 2278_UP | |
| Disease | Omenn Syndrome | 1.06e-05 | 19 | 67 | 3 | C2700553 | |
| Disease | Immature Reticulocyte Fraction Measurement | 2.26e-04 | 10 | 67 | 2 | EFO_0009253 | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 2.76e-04 | 11 | 67 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | aspartate aminotransferase measurement | 9.93e-04 | 904 | 67 | 8 | EFO_0004736 | |
| Disease | breast carcinoma (is_implicated_in) | 1.47e-03 | 25 | 67 | 2 | DOID:3459 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AWDPEKPSRSYSERD | 56 | P48751 | |
| YEMADDPDIWVRSRP | 1211 | Q9HCE6 | |
| EEPRDLPDNPERFEW | 366 | O00478 | |
| PPARQGSWEDEEEDY | 541 | Q02641 | |
| DRYWDSGPRADPVED | 586 | P78363 | |
| PADSRWVRDPRYRED | 616 | Q9NWN3 | |
| LPYEDSTWERRQDID | 911 | Q9P2D1 | |
| YRDFPSSPEPDWDNE | 676 | Q01814 | |
| EDPDYYGQEIWSREP | 31 | Q8N436 | |
| DEVLQDVYRDWTPPS | 606 | Q149M9 | |
| WEHSPYARREEERDP | 676 | Q5T481 | |
| YARREEERDPAPWRD | 681 | Q5T481 | |
| DEEDQDWFIPSRDLP | 66 | Q9ULR5 | |
| RREESLEKEPEYVPW | 751 | Q8WUM0 | |
| PEQDNRYWRGREDVA | 1676 | P78559 | |
| YDSNIDDWIPVPELR | 436 | Q9Y6Y0 | |
| REYRLDKEESPAPWD | 56 | Q8NHJ6 | |
| DYRKEGEEFPEEWLP | 31 | Q53EV4 | |
| EYIDDPRVQRIEPEW | 1036 | O75051 | |
| REENPWVPDDTYYCR | 1056 | Q9ULK4 | |
| EPEDYLNWRSPEDYV | 26 | Q0VF49 | |
| LYREPPEAIWADDVD | 516 | P30613 | |
| ELGWEALYEQRAEPR | 431 | A6NEY3 | |
| ELGWEALYEQRAEPR | 456 | A6NEF3 | |
| DWDYAPLVLAPDDRS | 411 | P00451 | |
| YLPVWRDNEETPFEV | 221 | Q9UHC3 | |
| EPEEWIPRTYQDLDG | 1016 | Q9C091 | |
| PEPSDWDRFAAEEYE | 1081 | Q06190 | |
| EPEEPADWQTYREDE | 5041 | Q5VST9 | |
| DYWLRRFEAEPLPEN | 271 | Q9BTU6 | |
| EVAWPYAETPEALAR | 36 | Q5T013 | |
| WEDPGIQECYDRRRE | 136 | P29992 | |
| REPPPWENEATERIY | 126 | P01589 | |
| ERYEPERDEWHLVAP | 441 | Q14145 | |
| EWRPAEEPRSYPDEE | 116 | Q8NBJ5 | |
| VEWRPMDEPESYPDE | 116 | Q8IYK4 | |
| LQEVYEPDWPGRDEA | 86 | O00499 | |
| RYVIEARPSDEGLWD | 1856 | Q58EX2 | |
| RERADEPQWSLYPSD | 131 | P05060 | |
| RAPRPQSEESWDEED | 371 | P05060 | |
| NEDPEYQWIDRIRTP | 171 | Q86YS7 | |
| PDGNEWASLTEYPRE | 106 | Q9H6A0 | |
| WVIYPAVDDRDEAQP | 531 | Q68BL7 | |
| PAPAEIEQEYWRLVE | 841 | Q92833 | |
| WISEDDFYRPSREQP | 441 | Q9Y4G2 | |
| APESWPQRSYDILER | 781 | O95197 | |
| PQEDERPADEYDQPW | 171 | Q96IW2 | |
| PQDDDRPADEYDQPW | 326 | Q15464 | |
| EELDSYRRGEEWDPQ | 116 | O75391 | |
| ASAVPAPDFEWYRDD | 241 | Q13449 | |
| YRDRAEWADIDPVPQ | 66 | P49354 | |
| DAYNPNTPEWREDVG | 971 | Q96PQ0 | |
| PEEERRAEFYHQPWS | 441 | Q6STE5 | |
| RRPVVVEPISDEDWY | 41 | Q96A35 | |
| EPGEDFPAARRLYWD | 111 | P02786 | |
| EVDWQDTRDDPYRPA | 131 | O14730 | |
| SPQYPHDGRDDREVW | 76 | P17643 | |
| LEEFEETPWSDQRPR | 146 | Q8IXZ2 | |
| YPDEPWRITEEQREY | 271 | Q8NFH8 | |
| RPDSLLSEERVWEYP | 301 | Q9P253 | |
| PDFSEQRWYEEEEPQ | 146 | O75414 | |
| DRSLDNEWDRDYGRP | 1301 | P49750 | |
| NEWDRDYGRPLDEQE | 1306 | P49750 | |
| DDWEPAALDPQEYPR | 86 | Q96CS4 | |
| NLDDYNPDIPEWRRD | 986 | Q8WY21 | |
| ENDERPAAEYEQPWE | 316 | Q5VZ18 | |
| YGVWAERDSDDERPS | 51 | Q9UBB9 | |
| PYVELKDSDGRPDWE | 646 | P35125 | |
| AETPTYPWRDAETGE | 31 | O95407 | |
| WPRRAQDEHPQEDGY | 91 | Q13459 | |
| YVVLAWEEPSPRDRA | 516 | Q5VTT5 | |
| DPQAWPSRYREALEE | 286 | Q99608 |